Purity Percentage: Why 99%+ Is a Standard, Not a Selling Point

Walk through the websites of enough peptide suppliers and you will find purity claims everywhere. 98%+. 99%+. Occasionally something vague like “high purity” with no number attached at all. For researchers who understand what they are working with, these numbers matter enormously. For those who are newer to sourcing research compounds, the difference between a real purity claim and a marketing claim can be harder to identify. This article explains what purity actually means in the context of research peptides, and what questions you should be asking before you order from any supplier.

What Purity Actually Means

In the context of lyophilized research peptides, purity refers to the percentage of the compound that is the intended molecule — as opposed to residual solvents, synthesis by-products, truncated sequences, deletion sequences, or other peptide-related impurities that arise during the manufacturing process.

A peptide that tests at 99%+ purity contains 99% or more of the target compound and less than 1% of everything else. At 95% purity, 5% of what you are working with is not what you think it is. In research terms, that is not a rounding error — it is a variable that can meaningfully affect your results.

The Difference Between Tested and Claimed

Here is the uncomfortable reality about the peptide supply chain: stating a purity percentage costs nothing. Verifying it costs something.

A legitimate purity claim is backed by analytical testing — most commonly High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS). These tests need to be performed by an independent, third-party laboratory on the specific batch being sold, with results traceable to a batch number that corresponds to the actual vials dispatched to the researcher.

What you should look for when evaluating any supplier’s purity claim:

A Certificate of Analysis (COA) — not a generic document, but a batch-specific COA with a lab name, test date, and results that correspond to the product you are purchasing.

Batch numbers — if a supplier cannot tell you which batch a COA belongs to, or if the COA does not reference a specific batch, the documentation is effectively meaningless.

Third-party testing — in-house testing is not verification. The laboratory conducting the analysis should be independent of the supplier.

Consistent testing across products — a supplier who tests some products and not others is telling you something important about how seriously they take quality control.

Why This Matters for Research Integrity

If you are conducting research where the compound is a variable — which it always is — then compound integrity is foundational. Inconsistent purity introduces noise. Contaminated compounds can produce confounding results. Truncated or deletion sequences can bind to unintended receptors. None of this is theoretical; it is documented in the scientific literature on research compound quality.

At Epigen, every product we dispatch comes with a batch-specific COA from an independent third-party laboratory. We do not sell product without it. Purity is not a feature we lead with because it sounds impressive — it is the baseline below which we simply do not operate.

What to Ask Any Supplier Before You Order

Before placing an order with any peptide supplier, ask three questions: Can you provide a batch-specific COA for this product? Which independent laboratory conducted the analysis? What is the batch number of the stock currently available?

If any of those questions are met with evasion, generalisation, or a generic document that does not reference your specific batch — you have your answer.

For Research Use Only

All products and information referenced in this article are intended strictly for research and laboratory use. Nothing in this article constitutes medical advice or a therapeutic recommendation.